featured
Rare Germline Variants Are Associated With Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study
Eur Urol 2022 May 31;[EPub Ahead of Print], D Burns, E Anokian, EJ Saunders, RG Bristow, M Fraser, J Reimand, T Schlomm, G Sauter, B Brors, J Korbel, J Weischenfeldt, SM Waszak, NM Corcoran, CH Jung, BJ Pope, CM Hovens, G Cancel-Tassin, O Cussenot, M Loda, C Sander, VM Hayes, K Dalsgaard Sorensen, YJ Lu, FC Hamdy, CS Foster, V Gnanapragasam, A Butler, AG Lynch, CE Massie, , DJ Woodcock, CS Cooper, DC Wedge, DS Brewer, Z Kote-Jarai, RA EelesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.